Skip to main content

Published locations for Dengue vaccine appears safe, immunogenic in children aged 2-17 years

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Dengue vaccine appears safe, immunogenic in children aged 2-17 years

User login

  • Reset your password
  • /content/dengue-vaccine-appears-safe-immunogenic-children-aged-2-17-years
  • /familypracticenews/article/140925/vaccines/dengue-vaccine-appears-safe-immunogenic-children-aged-2
  • /idpractitioner/article/140925/vaccines/dengue-vaccine-appears-safe-immunogenic-children-aged-2-17
  • /internalmedicinenews/article/140925/vaccines/dengue-vaccine-appears-safe-immunogenic-children-aged-2
  • /pediatricnews/article/140925/vaccines/dengue-vaccine-appears-safe-immunogenic-children-aged-2-17
  • /pediatrics/article/140925/vaccines/dengue-vaccine-appears-safe-immunogenic-children-aged-2-17-years
  • /infectiousdisease/article/140925/vaccines/dengue-vaccine-appears-safe-immunogenic-children-aged-2-17
  • /internalmedicine/article/140925/vaccines/dengue-vaccine-appears-safe-immunogenic-children-aged-2-17
  • /familymedicine/article/140925/vaccines/dengue-vaccine-appears-safe-immunogenic-children-aged-2-17